Literature DB >> 498585

Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.

G E Mortimer, J P Widdowson.   

Abstract

During investigation of the absorption of group-A streptococcal antibodies from human sera by a protein A-positive Staphylococcus aureus strain, we found that the complement-fixing antibodies to M-associated protein (MAP) were only partially absorbed from the majority of sera tested, although they were shown to belong to the immunoglobulin G (IgG) class by density gradient centrifugation. In contrast, other streptococcal antibodies: anti-streptolysin O (ASO), anti-deoxyribonuclease B (anti-DNAase B), 'bactericidal' M antibody and anti-opacity factor (anti-OF), were completely absorbed from all but a minority of sera. We suggest that the complement-fixing antibodies to MAP may be of restricted heterogeneity and have an abnormal IgG sub-class distribution, with a marked predominance of IgG3 (the only sub-class that does not interact with protein A) over the IgG1 and IgG2 sub-class; IgG4 does not participate in complement fixation. The concentration and relative porportions of IgG sub-classes are believed to be genetically influenced, so our findings may have some bearing on the immune responsiveness of different individuals to streptococcal infection, and possibly have important implications in the development of the secondary sequelae.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498585      PMCID: PMC1537815     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

2.  Detection of platelet-bound IgG with 125I-labelled staphylococcal protein A.

Authors: 
Journal:  Med Biol       Date:  1977-04

Review 3.  Biological activities of immunoglobulins of different classes and subclasses.

Authors:  H L Spiegelberg
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

Review 4.  Chemistry and reaction mechanisms of complement.

Authors:  H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

5.  A rapid immunofluorescent procedure for the detection of specific IgG and IgM antibody in sera using Staphylococcus aureus and latex-IgG as absorbents.

Authors:  S Chantler; E Devries; P R Allen; B A Hurn
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

6.  A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci.

Authors:  G Kronvall
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

7.  Quantitation of serum antibodies to surface antigens of Neisseria gonorrhoeae with radiolabeled protein A of Staphylococcus aureus.

Authors:  K K Christensen; P Christensen; P A Mårdh; L Weström
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

8.  Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus.

Authors:  R Hällgren; L Wide
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

9.  Single-tube mixed agglutination test for the detection of staphylococcal protein A.

Authors:  P E Maxim; H L Mathews; H F Mengoli
Journal:  J Clin Microbiol       Date:  1976-11       Impact factor: 5.948

10.  Persistence of type-specific antibodies in man following infection with group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

View more
  14 in total

1.  Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma.

Authors:  Mohammad M Sajadi; George K Lewis; Michael S Seaman; Yongjun Guan; Robert R Redfield; Anthony L DeVico
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.

Authors:  V A Sundqvist; A Linde; B Wahren
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

3.  Pigeon breeders' lung; IgG subclasses to pigeon intestinal mucin and IgA antigens.

Authors:  A Todd; R Coan; A Allen
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

4.  The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients.

Authors:  A M Elassad; S A Younis; M Siddig; J Grayson; E Petersen; H W Ghalib
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

5.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections.

Authors:  I Julkunen; T Hovi; I Seppälä; O Mäkelä
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

7.  Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.

Authors:  I Julkunen; P Ukkonen; M Stenvik; T Hovi; L Renkonen; O Mäkelä
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

8.  Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.

Authors:  W P Kaschka; R Hilgers; F Skvaril
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

9.  Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents.

Authors:  E M el Amin; E P Wright; A Vlug
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Protein synthesis in rheumatoid synovial tissue.

Authors:  J D Smiley; W L Hoffman
Journal:  Springer Semin Immunopathol       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.